Position in EDIT
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$850,903
+$177,664 QoQ
Shares Held
262,625
-3.6% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. EDIT ranks #206 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in EDIT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $850,903 | 262,625 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $673,239 | 272,567 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $502,950 | 245,342 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $918,462 | 264,687 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $535,538 | 243,427 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $271,382 | 233,951 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $309,085 | 243,376 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $828,331 | 242,913 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,383,038 | 296,154 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $2,113,378 | 284,822 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $3,173,343 | 313,262 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $2,451,024 | 314,234 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,264,548 | 275,158 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,911,584 | 263,667 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,277,681 | 256,785 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,100,279 | 253,291 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,755,961 | 232,964 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,494,458 | 288,878 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $7,641,567 | 287,818 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,384,016 | 301,461 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $15,477,106 | 273,254 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $10,669,764 | 254,042 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $19,630,377 | 279,994 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $7,008,797 | 249,779 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $9,357,957 | 316,361 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $5,076,042 | 255,978 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||